February

February 22, 2015

Mechanistic insights into tumor suppression: Ribosomal protein S14 suppresses the expression of oncomiR 17-92 via down regulation of its target gene, 22/February/2015, 16.14

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Mechanistic insights into tumor suppression: Ribosomal protein S14 suppresses the expression of oncomiR 17-92 via down regulation […]
February 22, 2015

Natural product-based Life-extension therapy: Epigallocatechin-3-Gallate, the major component of Green tea, increases life span by inducing the expression of its target gene, 22/February/2015, 11.27 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Significance: Epigallocatechin-3-Gallate, the major component of Green tea, may increase life span by inducing its target gene. Together, pharmacological formulations encompassing “Epigallocatechin-3-Gallate or its analogues“ may function […]
February 22, 2015

Molecular based therapy for NIDDM: Jagged1 inhibits gluconeogenesis and hyperglycemia via up regulation of CyclinD1, 22/February/2014, 9.13 am

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently […]
February 21, 2015

MiRNA-based molecular therapy for Right ventricular cardiomyopathy: Repressor-element-1-silencing transcription factor suppresses arrhythmogenic right ventricular cardiomyopathy via down regulation of its target gene, 22/February/2015, 12.09 am

A recent study from the Ludwig Institute for Cancer Research Limited, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom shows that “iASPP, a previously […]